Nifty

:

17331.80

Sensex

:

58222.10

57.50 (0.33%)
156.63 (0.27%)

Login

Nifty
Sensex

:
:

17331.80
58222.10

57.50 (0.33%)
156.63 (0.27%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

54/99

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

682.15

06-Oct-2022

Day's Open
Day's High
Day's Low
Previous Close

684.90
691.00
680.10
684.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4172
28.56
927.00
565.30

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,687.37
39.82
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,169.74
1.46%
2.26

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-7.83
-6.64
-3.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-11.73
-
16.79

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

32.43
49.87
64.52

P:BV (Average)

8 Years
5 Years
3 Years

2.34
2.34
2.34

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.85
14.19
17.84

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 120.92 98.11 23.25% 98.32 99.29 -0.98% 98.96 93.77 5.53% 104.48 95.83 9.03%
Expenses 89.12 90.27 -1.27% 92.70 84.02 10.33% 92.40 96.65 -4.40% 97.39 85.62 13.75%
EBITDA 31.80 7.84 305.61% 5.62 15.27 -63.20% 6.56 -2.88 - 7.09 10.21 -30.56%
EBIDTM 26.30% 7.99% 5.72% 15.38% 6.63% -3.07% 6.79% 10.65%
Other Income 26.52 6.46 310.53% 14.31 12.27 16.63% 6.04 8.26 -26.88% 6.38 5.60 13.93%
Interest 0.50 1.54 -67.53% 0.33 2.72 -87.87% 1.46 1.62 -9.88% 1.50 1.66 -9.64%
Depreciation 1.30 2.91 -55.33% 1.31 2.92 -55.14% 2.75 3.08 -10.71% 2.68 3.10 -13.55%
PBT 56.52 9.85 473.81% -31.35 21.90 - 8.39 0.68 1,133.82% 9.29 11.05 -15.93%
Tax 4.14 3.57 15.97% -7.98 12.20 - 2.04 1.39 46.76% 2.27 3.53 -35.69%
PAT 52.38 6.28 734.08% -23.37 9.70 - 6.35 -0.71 - 7.02 7.52 -6.65%
PATM 43.32% 6.40% -23.77% 9.77% 6.42% -0.76% 6.72% 7.85%
EPS 21.21 2.54 735.04% -9.46 3.93 - 2.57 -0.29 - 2.84 3.04 -6.58%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 422.68 399.87 381.35 438.25 490.68 563.89 656.22 689.77 873.38 862.23 903.36 Net Sales Growth 9.22% 4.86% -12.98% -10.69% -12.98% -14.07% -4.86% -21.02% 1.29% -4.55% Cost Of Goods Sold 195.66 178.14 146.61 182.32 198.65 245.51 306.10 286.31 349.02 386.65 367.39 Gross Profit 227.02 221.73 234.74 255.93 292.03 318.38 350.12 403.46 524.36 475.58 535.97 GP Margin 53.71% 55.45% 61.56% 58.40% 59.52% 56.46% 53.35% 58.49% 60.04% 55.16% 59.33% Total Expenditure 371.61 374.36 355.66 426.51 478.54 572.12 631.70 658.95 881.18 865.65 814.48 Power & Fuel Cost - 0.53 0.53 1.27 1.79 2.56 1.77 4.43 4.87 4.02 3.57 % Of Sales - 0.13% 0.14% 0.29% 0.36% 0.45% 0.27% 0.64% 0.56% 0.47% 0.40% Employee Cost - 101.89 108.51 113.87 117.11 144.53 139.30 156.66 200.03 174.19 162.30 % Of Sales - 25.48% 28.45% 25.98% 23.87% 25.63% 21.23% 22.71% 22.90% 20.20% 17.97% Manufacturing Exp. - 34.49 36.52 39.23 42.21 42.07 49.03 62.35 98.47 104.52 97.61 % Of Sales - 8.63% 9.58% 8.95% 8.60% 7.46% 7.47% 9.04% 11.27% 12.12% 10.81% General & Admin Exp. - 18.61 12.95 23.40 43.28 45.74 45.74 47.65 64.48 62.19 64.16 % Of Sales - 4.65% 3.40% 5.34% 8.82% 8.11% 6.97% 6.91% 7.38% 7.21% 7.10% Selling & Distn. Exp. - 35.66 39.77 53.99 60.29 72.48 75.83 70.74 131.14 101.63 90.68 % Of Sales - 8.92% 10.43% 12.32% 12.29% 12.85% 11.56% 10.26% 15.02% 11.79% 10.04% Miscellaneous Exp. - 5.04 10.77 12.43 15.21 19.23 13.93 30.81 33.17 32.45 90.68 % Of Sales - 1.26% 2.82% 2.84% 3.10% 3.41% 2.12% 4.47% 3.80% 3.76% 3.18% EBITDA 51.07 25.51 25.69 11.74 12.14 -8.23 24.52 30.82 -7.80 -3.42 88.88 EBITDA Margin 12.08% 6.38% 6.74% 2.68% 2.47% -1.46% 3.74% 4.47% -0.89% -0.40% 9.84% Other Income 53.25 34.79 34.19 36.43 78.40 173.81 71.52 244.55 111.58 97.24 84.35 Interest 3.79 4.83 7.68 6.39 1.59 5.53 0.72 0.21 0.21 0.27 0.22 Depreciation 8.04 9.65 12.16 13.14 3.18 2.53 3.59 3.49 4.01 3.65 3.59 PBT 42.85 45.82 40.04 28.64 85.77 157.52 91.73 271.67 99.56 89.90 169.42 Tax 0.47 -0.10 19.14 18.56 34.00 79.16 34.51 73.38 14.12 -8.63 49.69 Tax Rate 1.10% 2.62% 47.80% 64.80% 39.64% 50.25% 37.62% 27.01% 15.15% -9.60% 29.33% PAT 42.38 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 98.53 119.73 PAT before Minority Interest 42.38 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 98.53 119.73 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.03% -0.93% 5.48% 2.30% 10.55% 13.90% 8.72% 28.75% 9.06% 11.43% 13.25% PAT Growth 85.96% - 107.34% -80.53% -33.93% 36.95% -71.14% 150.65% -19.71% -17.71% EPS 17.16 -1.51 8.46 4.08 20.96 31.72 23.17 80.28 32.03 39.89 48.47

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 691.70 711.19 720.73 759.19 733.64 919.64 1,193.58 1,001.99 961.35 900.21 Share Capital 12.34 12.34 12.34 12.34 12.34 14.07 15.98 15.98 15.98 15.98 Total Reserves 681.58 701.80 711.68 751.10 727.48 913.00 1,184.54 986.01 945.37 884.23 Non-Current Liabilities 999.92 1,130.65 99.38 891.47 897.75 827.53 26.47 696.64 585.68 560.05 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1,007.50 1,109.57 65.93 909.70 916.30 844.46 45.85 714.94 600.01 572.48 Current Liabilities 334.47 357.26 416.93 367.22 481.74 323.21 204.49 361.82 458.91 492.87 Trade Payables 72.20 55.20 72.60 91.40 106.11 73.22 69.66 94.52 107.52 119.59 Other Current Liabilities 45.34 69.64 132.99 67.62 184.52 63.26 88.94 52.24 47.58 40.69 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 216.93 232.42 211.34 208.20 191.11 186.73 45.89 215.06 303.81 332.59 Total Liabilities 2,026.09 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94 1,953.13 Net Block 23.65 63.91 76.28 14.98 4.60 5.71 6.48 8.50 7.87 9.96 Gross Block 32.94 74.81 85.08 23.93 12.09 10.82 9.87 26.08 23.98 25.74 Accumulated Depreciation 9.29 10.90 8.80 8.95 7.49 5.11 3.39 17.58 16.11 15.78 Non Current Assets 1,199.31 1,276.75 239.77 1,029.20 1,008.86 958.91 160.85 845.95 698.16 638.95 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.01 0.45 0.00 0.00 0.27 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.03 Long Term Loans & Adv. 1,148.17 1,186.01 137.84 989.61 979.98 935.98 153.29 837.20 690.13 628.60 Other Non Current Assets 27.49 26.83 25.65 24.61 24.28 17.21 0.63 0.24 0.13 0.09 Current Assets 826.78 922.35 997.27 988.68 1,104.27 1,111.47 1,263.69 1,214.50 1,307.78 1,314.18 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 57.07 47.95 58.68 60.51 56.56 87.52 72.40 99.94 103.59 110.15 Sundry Debtors 44.56 38.73 37.60 45.59 43.91 40.83 50.17 82.90 77.40 82.44 Cash & Bank 517.63 498.88 581.91 612.02 775.08 815.72 1,125.55 838.55 16.81 39.30 Other Current Assets 207.52 46.30 59.09 34.54 228.72 167.40 15.57 193.11 1,109.98 1,082.29 Short Term Loans & Adv. 193.13 290.49 259.99 236.02 202.29 146.86 9.99 190.34 1,109.75 1,069.70 Net Current Assets 492.31 565.09 580.34 621.46 622.53 788.26 1,059.20 852.68 848.87 821.31 Total Assets 2,026.09 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94 1,953.13

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 38.67 -69.21 -23.14 -194.28 160.99 -40.83 56.59 -59.59 -4.56 7.43 PBT -3.82 40.04 28.64 85.77 157.52 91.73 111.37 99.56 89.90 169.42 Adjustment -5.64 -4.98 -11.80 -72.66 -55.87 -55.95 -67.04 -84.63 -74.44 -70.96 Changes in Working Capital 66.72 -69.08 -1.85 -161.76 117.30 -32.45 91.70 -31.81 10.76 -30.41 Cash after chg. in Working capital 57.26 -34.02 14.99 -148.65 218.95 3.33 136.03 -16.88 26.22 68.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -18.59 -35.19 -38.13 -45.63 -57.96 -44.16 -79.44 -36.38 -30.78 -60.62 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -6.33 0.00 0.00 Cash From Investing Activity 87.04 95.16 55.91 274.23 68.70 423.64 -630.47 718.94 22.16 -16.06 Net Fixed Assets 41.87 10.27 -61.15 -11.84 -1.26 -0.51 15.76 -2.10 2.03 -2.38 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00 0.00 Others 45.17 84.89 117.06 286.07 69.96 424.15 -646.24 721.02 20.13 -13.68 Cash from Financing Activity -35.63 -36.80 -41.41 -29.82 -267.65 -331.80 -38.57 -37.67 -37.79 -37.33 Net Cash Inflow / Outflow 90.08 -10.85 -8.64 50.13 -37.96 51.01 -612.45 621.68 -20.19 -45.96 Opening Cash & Equivalents 68.27 79.12 87.76 37.63 75.59 24.58 637.03 15.35 35.54 81.50 Closing Cash & Equivalent 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03 15.35 35.54

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 281.17 289.36 293.36 309.34 299.76 329.45 375.63 313.51 300.80 281.67 ROA -0.18% 1.22% 0.62% 2.51% 3.75% 3.27% 11.38% 3.89% 4.98% 6.39% ROE -0.53% 2.91% 1.36% 6.89% 9.40% 5.38% 18.01% 8.06% 10.59% 13.94% ROCE 0.14% 6.67% 4.73% 11.70% 19.72% 8.75% 24.77% 9.52% 9.69% 19.74% Fixed Asset Turnover 9.03 5.68 9.77 32.72 59.76 63.43 38.38 34.93 34.80 36.80 Receivable days 31.23 30.70 28.50 27.72 22.59 25.31 35.20 33.46 33.71 30.68 Inventory Days 39.38 42.89 40.83 36.25 38.41 44.47 45.59 42.48 45.08 38.08 Payable days 130.52 159.09 74.34 84.28 68.27 44.09 50.69 46.89 53.76 52.77 Cash Conversion Cycle -59.90 -85.49 -5.01 -20.31 -7.27 25.70 30.10 29.04 25.04 15.99 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 0.21 6.21 5.48 54.94 29.48 128.40 1294.67 444.95 333.96 771.09

Top Investors:

llp, partnership firm, directors' relative

Annual Reports:

News Update:

Novartis - Quarterly Results
27th Jul 2022, 15:57 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback